SCHEMBL4725102

SCHEMBL4725102

O=C1C=CC2=C(C1)NCC2

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
CRBN Q96SW2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15570455 0.65 GSK3A (0.42) GSK3AGSK3BCRBN
SCHEMBL277815 0.63
SCHEMBL1126452 0.63 GSK3A (0.39) GSK3AGSK3B
SCHEMBL13587063 0.62
SCHEMBL5468608 0.60 GSK3A (0.40) GSK3AGSK3B
SCHEMBL9527717 0.59 GSK3A (0.46) GSK3AGSK3B
SCHEMBL10381529 0.59 GSK3A (0.46) GSK3AGSK3B
SCHEMBL943110 0.59 GSK3A (0.46) GSK3AGSK3B
SCHEMBL366153 0.58 GSK3A (0.71) GSK3AGSK3B
SCHEMBL30766303 0.58 GSK3A (0.43) GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008020180-A2 METHODS OF INCREASING THE SENSITIVITY OF CANCER CELLS TO DNA DAMAGE KUDOS PHARMACEUTICALS LIMITED (GB) 2008-02-21 WO disclosed
EP-1684736-A1 DNA DAMAGE REPAIR INHIBITORS FOR TREATMENT OF CANCER Kudos Pharmaceuticals Limited (GB) 2006-08-02 EP disclosed
WO-2005053662-A1 DNA DAMAGE REPAIR INHIBITORS FOR TREATMENT OF CANCER KUDOS PHARMACEUTICALS LIMITED (GB) 2005-06-16 WO disclosed